222bc5e1fe32bed60f7dfa392f0480bb

Subscribe today

© 2025 The Bottom Line

For The Curious

Behind the Scenes

Duke’s grip on Briscoe poses liquidity question

Passive funds might find it hard to fill their boots.

Click here

USX-listed PharmaZen grappling with sour shareholder relations

Its European shareholder is driving a hard bargain.

Click here

Fisher’s private equity play may ultimately help IPO pipeline

Some PE scrutiny might get a few more local firms ready to go public.

Click here

NZME pruning gets cautious approval from analysts

The media sector is in for a rocky ride.

Click here

Growing pains dent FNZ’s 2024; no word on shareholder stoush

Trading platform Hatch is generating positive cash flow.

Click here

FirstCape sees strength in Consilium’s adviser ties

The fund manager’s acquisition isn’t just about growing funds.

Click here

Rainmakers: Your country needs you!

The government will let Invest NZ know who its favourites are.

Click here

Behind the Scenes

Ex-directors hitch ride on Constellation’s Eroad exit

Ellerston Capital has upped its stake.

Click here

The Bottom Line - free

We need to talk about savings and investment

The FMA is trying to understand people’s understanding of finance.

Click here

Foodstuffs SI wary of govt; tax depreciation changes weigh

The southerners are trying to strengthen its base of supermarket owners.

Click here

The Bottom Line - free

Tait emerges as bidder for Vital in $18.7m takeover tilt

The shares jumped past a two-year high to close in on the offer price.

Click here

Tempered expectations as blue-chip earnings loom

Infratil, F&P Healthcare, Mainfreight and Ryman are due this week.

Click here

Wolfbrook shows some ankle in Syndex offering

The FMA is pondering the world of wholesale investors.

Click here

Load more